tailieunhanh - Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: A comparative study

Camptothecin (CPT) and its derivatives are currently used as second- or third-line treatment for patients with endocrine-resistant breast cancer (BC). | Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells A comparative study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN